GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now becoming a significant focus in therapeutic studies, largely due to its notable impact on treating conditions such as type 2 diabetes and excess body fat. Recent studies have shown that more than glucose control, GLP-1 drugs offer benefits for heart health and even neurodegenerative